Influence of menthol on caffeine disposition and pharmacodynamics in healthy female volunteers

European Journal of Clinical Pharmacology

Volumn 59, Issue 5-6, 2003, Pages 417-422

  Gelal, Ayse ^a   Guven, Hulya ^a   Balkan, Dilara ^a   Artok, Levent ^b   Benowitz, Neal L ^c  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b IZMIR INSTITUTE OF TECHNOLOGY   (Turkey)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Caffeine; Menthol; Monoterpenes

Indexed keywords

CAFFEINE; CYTOCHROME P450 1A2; MENTHOL; PLACEBO;

ADULT; ARTICLE; CAPSULE FILLING; CARDIOVASCULAR FUNCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG EFFECT; DRUG HALF LIFE; DRUG METABOLISM; FEMALE; HEALTH STATUS; HEART RATE; HUMAN; HUMAN EXPERIMENT; KINETICS; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; VOLUNTEER;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AREA UNDER CURVE; CAFFEINE; COFFEE; CROSS-OVER STUDIES; CYTOCHROME P-450 CYP1A2; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; FEMALE; HALF-LIFE; HEART RATE; HUMANS; MENTHOL; MIDDLE AGED; TIME FACTORS;

EID: 0141594697     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-003-0631-1     Document Type: Article

References (29)

1. Opdyke DL (1976) Monographs on fragrance raw materials 1-menthol. Food Cosmetic Toxicol 14:471-472
2. Eccles R (1994) Menthol and related cooling compounds. J Pharm Pharmacol 46:618-630
3. Baytop T (1999) Therapy with medicinal plants in Turkey (past and present). Nobel, Istanbul, pp 302-303
4. Madyastha KM, Srivastan V (1988) Studies on the metabolism of 1-menthol in rats. Drug Metab Dispos 16:765-772
5. Austin CA, Shephard EA, Pike SF, Rabin BR, Phillips IR (1988) The effect of terpenoid compounds on cytochrome P-450 levels in rat liver. Biochem Pharmacol 37:2223-2229
6. De-Olivera ACAX, Fidalgo-Neto AA, Paumgartten F JR (1999) In vitro inhibition of liver monooxygenases by β-ionone, 1,8-cineole, (-)-menthol and terpinol. Toxicol 135:33-41
7. Wacher V, Wong S, Wong HT (2002) Peppermint oil enhances cyclosporine oral bioavailability in rats: comparison with D-α-tocopheryl poly(ethylene glycol 1000) succinate (TPGS) and ketoconazole. J Pharm Sci 91:77-90
8. Dresser GK, Wacher V, Wong S, Wong HT, Bailey DG (2002) Evaluation of peppermint oil and ascorbyl palmitate as inhibitors of cytochrome P4503A4 activity in vitro and in vivo. Clin Pharmacol Ther 72:247-255
9. Carrillo JA, Benitez J (2000) Clinically significant pharmacokinetic interactions between dietary caffeine and medications. Clin Pharmacokinet 39:127-153
10. Miners JO, Birkett DJ (1996) The use of caffeine as a metabolic probe for human drug metabolizing enzymes. Gen Pharmacol 27:245-249
11. Anderson GD (2002) Sex differences in drug metabolism: cytochrome P-450 and uridine diphosphate glucuronosyl-transferase. J Gend Specif Med 5:25-33
12. 2 in humans. Biol Mass Spectrom 20:247-252
13. Steinijans VW, Hartmann M, Huber R, Radtke HW (1991) Lack of pharmacokinetic interaction as an equivalence problem. Int J Clin Pharmacol Ther Toxicol 29:323-328
14. Gelal A, Jacob P, Yu L, Benowitz NL (1999) Disposition kinetics and effects of menthol. Clin Pharmacol Ther 66:128-135
15. Sawynok J, Yaksh TL (1993) Caffeine as an analgesic adjuvant: A review of pharmacology and mechanisms of action. Pharmacol Rev 45:43-85
16. Taylor BA, Luscombe DK, Duthie HL (1983) Inhibitory effect of peppermint oil on gastrointestinal smooth muscle. Gut 24:A992
17. Taylor BA, Luscombe DK, Duthie HL (1984) Inhibitory effect of peppermint oil and menthol on human isolated coli. Gut 25:A 1168-A1169
18. Taylor BA, Duthie HL, Luscombe DK (1985) Calcium antagonist activity of menthol on gastrointestinal smooth muscle. Br J Clin Pharmacol 20:293-294
19. Micklefield GH, Greving I, May B (2000) Effects of peppermint oil and caraway oil on gastroduodenal motility. Phytother Res 14:20-23
20. Hawthorn M, Ferrante J, Luchoswki E, Rutledge A, Wei XY, Triggle DJ (1988) The actions of peppermint oil and menthol on calcium channel dependent processes in intestinal, neuronal and cardiac preparations. Aliment Pharmacol Ther 2:101-118
21. Madyastha P, Moorthy B, Vaidyanathan CS, Madyastha KM (1985) In vivo and in vitro destruction of rat liver cytochrome P-450 by a monoterpene ketone, pulegone. Biochem Biophys Res Commun 128:921-927
22. Madyastha KM, Chadha A (1986) Metabolism of 1,8-cineole in rat: its effects on liver and lung microsomal cytochrome P- 450 systems. Bull Environ Contam Toxicol 37:759-766
23. 3H]-l-menthol in the rat. Drug Metab Dispos 22:616-624
24. Bell GD, Dutka DP, Henry DA, Langman MJS (1981) Glucuronidation of 1-menthol in man: the effects of prior treatment with cimetidine and phenobarbitone (abstract). Br J Clin Pharmacol 12:274P
25. Denaro CP, Benowitz NL (1991) Caffeine metabolism. Disposition in liver disease and hepatic function testing. In: Watson RR (ed) Drug and alcohol reviews, vol 2: liver pathology and alcohol. The Humana Press Inc, pp 513-539
26. Benowitz NL (1990) Clinical pharmacology of caffeine. Annu Rev Med 41:277-288
27. Robertson D, Frolich JC, Carr R, Watson JT, Hollifield JW (1978) Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med 298:181-186
28. Sharp DS, Benowitz NL (1990) Pharmacoepidemiology of the effect of caffeine on blood pressure. Clin Pharmacol Ther 47:57-60
29. Pritchard WS, Houlihan ME, Guy TD, Robinson JH (1999) Little evidence that 'denicotinized' menthol cigarettes have pharmacological effects: an EEG/ heart rate/subjective-response study. Psychopharmacology 143:273-279